Guest guest Posted May 10, 2009 Report Share Posted May 10, 2009 Ralph W. Moss, Ph.D. Weekly CancerDecisions.com Newsletter #391 05/10/09 CANCER DECISIONS FREE WEEKLY NEWSLETTER NCI QUESTIONS ADRIAMYCIN The National Cancer Institute (NCI) has issued a very negative report on the drug Adriamycin (doxorubin) as well the other anthracycline drugs (epirubicin and idarubicin).... To read this week's newsletter, please click or go to: http://www.cancerdecisions.com/051009.html Quote Link to comment Share on other sites More sharing options...
Recommended Posts
Join the conversation
You are posting as a guest. If you have an account, sign in now to post with your account.
Note: Your post will require moderator approval before it will be visible.